{"schema_version":"secwatch.filing_event.v1","accession":"0001459839-22-000012","form_type":"8-K","ticker":"SIBN","cik":"0001459839","company_name":"SI-BONE, Inc.","filed_at":"2022-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.549249+00:00","generated_at":"2026-06-27T03:33:02.250132+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"SI-BONE reports Q4 2021 revenue $25.2M (+14% YoY); net loss $0.43/share; FY2022 guidance $106-108M","bullets":["Q4 2021 revenue $25.2M, up 14% YoY; full-year 2021 revenue $90.2M, up 23% YoY.","Q4 net loss $14.5M ($0.43/diluted share) vs $9.0M ($0.28) in Q4 2020.","Gross margin 87% in Q4 2021 (90% in Q4 2020); full-year gross margin 88%.","Cash and marketable securities $147.0M as of Dec 31, 2021.","FY2022 revenue guidance $106M-$108M (18-20% growth); cautious on COVID impact on elective procedures."],"urls":{"canonical":"https://secwatch.observer/filing/0001459839-22-000012","json":"https://secwatch.observer/filing/0001459839-22-000012.json","markdown":"https://secwatch.observer/filing/0001459839-22-000012.md","text":"https://secwatch.observer/filing/0001459839-22-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1459839/000145983922000012/0001459839-22-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1459839/000145983922000012/sibn-20220228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T03:33:02.250132+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}